6.5K views · 60 reactions | The European Medicines Agency has found that the benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks. But the regulator said a warning should be added to labels about a possible link to a very rare occurrence of blood clots with low blood platelets. The National Immunisation Advisory Committee will now decide what, if any, changes to make to the planned use of the vaccine here. | https://bit.ly/3v6mlPr | RTÉ News | Facebook